Evidence map›Paper›PMID 34365116›Full record

ArticleDNA repair2021

CometChip enables parallel analysis of multiple DNA repair activities.

Jing Ge, Le P Ngo, Simran Kaushal, Ian J Tay, Elina Thadhani, Jennifer E Kay, Patrizia Mazzucato, Danielle N Chow, Jessica L Fessler, David M Weingeist and 4 more

Erratum issuedAbstract read
In one paragraph

Article in DNA repair, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Jing GeDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Le P NgoDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Simran KaushalDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, United States.
Ian J TayDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Elina ThadhaniDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Jennifer E KayDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Patrizia MazzucatoDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Danielle N ChowDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Jessica L FesslerDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
David M WeingeistDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Robert W SobolDepartment of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States; University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA 15213, United States.
Leona D SamsonDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Scott R FloydDepartment of Radiation Oncology, Duke University School of Medicine, Durham, NC 27514, United States.
Bevin P EngelwardDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States. Electronic address: bevin@mit.edu.

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous ChemicalsP42ES027707 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Bevin P. Engelward · 2017 to 2026
$22.2M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
DNA repair deficient cells for analysisR44GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2010 to 2011
$2.5M
Eukaryotic DNA Alkylation RepairR01ES022872 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SAMSON, LEONA D. · 2013 to 2017
$1.7M
DNA repair deficient human cells for genomic variation analysisR43GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2009 to 2009
$200k
NCI NIH HHS R01 CA148629NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P42 ES027707NIEHS NIH HHS R01 ES022872NIGMS NIH HHS R43 GM087798NIGMS NIH HHS R44 GM087798
6 · The paper itself

Abstract

DNA damage can be cytotoxic and mutagenic, and it is directly linked to aging, cancer, and other diseases. To counteract the deleterious effects of DNA damage, cells have evolved highly conserved DNA repair pathways. Many commonly used DNA repair assays are relatively low throughput and are limited to analysis of one protein or one pathway. Here, we have explored the capacity of the CometChip platform for parallel analysis of multiple DNA repair activities. Taking advantage of the versatility of the traditional comet assay and leveraging micropatterning techniques, the CometChip platform offers increased throughput and sensitivity compared to the traditional comet assay. By exposing cells to DNA damaging agents that create substrates of Base Excision Repair, Nucleotide Excision Repair, and Non-Homologous End Joining, we show that the CometChip is an effective method for assessing repair deficiencies in all three pathways. With these applications of the CometChip platform, we expand the utility of the comet assay for precise, high-throughput, parallel analysis of multiple DNA repair activities.

Indexed as

DNA DamageDNA RepairCell LineCell Line, TumorComet AssayDNADNA End-Joining RepairHigh-Throughput Screening AssaysHumansMutagensDNAMutagensComet assayCometChipDNA damageDNA repair

Identifiers

PMID34365116
PMCPMC8439179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.